Showing 1,101 - 1,120 results of 1,171 for search 'antibody effect function', query time: 0.11s Refine Results
  1. 1101

    Heart crosstalk with other organs and pharmacological strategies for cardioprotection by Zizhuo TU, Yaozu XIANG

    Published 2022-03-01
    “…Drugs targeting the regulation of pathways related to hepatic lipid metabolism, intestinal flora, renal sodium excretion and hypoglycemia, bone marrow clonal hematopoiesis and immune inflammation, such as Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, Sodium-glucose Cotransporter-2 (SGLT2) inhibitors, IL-1β monoclonal antibodies and Chimeric antigen receptor (CAR) -T therapy, have been shown to have significant protective effects in the prevention and treatment of cardiovascular disease, especially ischemic heart disease and HF. …”
    Get full text
    Article
  2. 1102

    Immune Profile of COVID-19 Survivors and Contacts During 9 Months: A Cohort Study by Valentina V. Tatarnikova, Natalya O. Kiseleva, Valentina I. Dubrovina, Vladimir A. Vishnyakov, Darya D. Bryukhova, Anna B. Pyatidesyatnikova, Konstantin M. Korytov, Munko B. Sharakshanov, Sergey V. Balakhonov, Haijuan Wang

    Published 2023-10-01
    “…Little is known about the possible long-term effects of COVID-19 on circulating leukocyte kinetics and functional T-cell activity after recovery. …”
    Get full text
    Article
  3. 1103

    Role of the cellular immunity in the formation of the immune response in coronavirus infections by I. A. Ivanova, N. D. Omelchenko, A. V. Filippenko, A. A. Trufanova, A. K. Noskov

    Published 2021-12-01
    “…The data obtained during previous epidemics caused by coronaviruses, and current pandemic indicate that assessing the role of certain immune interactions between these viruses and the microorganism is the main pre-requisite for development of diagnostic test systems as well as effective medical drugs and preventive measures. The review summarizes the results of studying patho– and immunogenesis of SARSCoV, MERS-CoV, and SARS-CoV-2 infections. …”
    Get full text
    Article
  4. 1104
  5. 1105

    How breastfeeding affects immunity? by Dawid Piecuch, Weronika Sobota, Katarzyna Zemsta, Przemysław Piskorz, Michał Zwoliński, Edyta Hańczyk, Aleksandra Sędek

    Published 2025-01-01
    “…Mechanisms that cause side effects that cause effects not only in the aftermath of life, but also in the aftermath of health in the aftermath of life. …”
    Get full text
    Article
  6. 1106

    Features of the formation of specific immunity after vaccination against viral hepatitis B in children and young people by E. O. Kochetova, O. V. Shamsheva, I. V. Polesko, A. V. Semenenko, O. A. Maiorova, V. V. Belyakova, V. V. Gorev

    Published 2023-07-01
    “…Thus, due to the weak response to the recombinant hepatitis B vaccine and the high medical and social significance of hepatitis B infection, various approaches are currently being developed to enhance the effectiveness of vaccination: changes in the vaccination regimen; correction of immune system functions to restore an adequate response to vaccine preparations, the use of various adjuvants, including recombinant interferons.…”
    Get full text
    Article
  7. 1107

    Potential biomarker and composite efficacy readout for human clinical trials of schistosomiasis vaccine in Africa by Desalegn W. Kifle, Aravindan Kalyanasundaram, Adebayo J. Molehin, Mumtaz Y. Balkhi, Aryandra Arya, Weidong Zhang, Gul Ahmad, Workineh Torben, David Carey, James F. Papin, Lisa A. Jackson, Sean A. Gray, Darrick Carter, Afzal A. Siddiqui

    Published 2025-07-01
    “…This reproducible functional assay has the potential to serve as one of the biomarkers for the effectiveness of the SchistoShield vaccine in human trials in Africa.…”
    Get full text
    Article
  8. 1108

    Revisiting the role of cancer-associated fibroblasts in tumor microenvironment by Xiaolei Lan, Wenyang Li, Kai Zhao, Jianpeng Wang, Shifang Li, Hai Zhao

    Published 2025-04-01
    “…However, challenges persist in understanding their heterogeneity, origin, and functional diversity. One major obstacle is the lack of standardized naming conventions for CAF subpopulations, with current systems failing to capture their full complexity. …”
    Get full text
    Article
  9. 1109

    HER3: Unmasking a twist in the tale of a previously unsuccessful therapeutic pursuit targeting a key cancer survival pathway by Omkar Desai, Moeez Rathore, Christina S. Boutros, Michel'le Wright, Elizabeth Bryson, Kimberly Curry, Rui Wang

    Published 2025-07-01
    “…While pre-clinical investigations have effectively showcased significant anti-cancer effects of HER3-targeted therapies, these therapies have had little impact on cancer patient outcomes in the clinic, except for patients with rare NRG1 fusion mutations. …”
    Get full text
    Article
  10. 1110

    Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice by Shih-Hsin Chang, Yun-Fei Ko, Jian-Ching Liau, Cheng-Yeu Wu, Tsong-Long Hwang, David M. Ojcius, John D. Young, Jan Martel

    Published 2025-04-01
    “…Methods: We examined the effects of the prebiotics, H. sinensis polysaccharides, and probiotic, P. goldsteinii, in a mouse model of imiquimod-induced systemic lupus erythematosus. …”
    Get full text
    Article
  11. 1111
  12. 1112

    Innate Immunity Stimulation during the COVID-19 Pandemic: Challenge by Parvulan by Beniamino Palmieri, Antonio Manenti, Francesca Galotti, Maria Vadalà

    Published 2022-01-01
    “…The asymptomatic SARS-CoV-2 patients who were incidentally enrolled in our survey were tested at the sixth month for antibodies against SARS-CoV-2, and 14 patients had high levels of SARS-CoV-2 antibodies. …”
    Get full text
    Article
  13. 1113

    Pain mediator NGF improves chondrocyte extracellular matrix synthesis via PI3K/AKT pathway by Mengling Wang, Jie Lian, Maoqing Ye, Bingchen An

    Published 2025-02-01
    “…Clinical studies revealed that anti-NGF antibodies are often accompanied by progressively worsening cartilage degeneration, although they exhibit significant analgesic effects. …”
    Get full text
    Article
  14. 1114

    Boron delivery agents in BNCT: A mini review of current developments and emerging trends by Rolemae M. Murilla, Gladys G. Edilo, Marco Laurence M. Budlayan, Eulogio S. Auxtero, Jr.

    Published 2025-12-01
    “…This review provides a comprehensive analysis of current developments in boron delivery systems, offering insights into their potential to transform BNCT into a more effective and accessible cancer therapy.…”
    Get full text
    Article
  15. 1115

    Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives by Sarkar Sardar Azeez, Raya Kh. Yashooa, Shukur Wasman Smail, Abbas Salihi, Azhin Saber Ali, Sami Mamand, Christer Janson

    Published 2025-07-01
    “…Furthermore, combination therapies, including chemotherapy, radiotherapy, antibodies, small molecule inhibitors, cancer vaccines, oncolytic viruses, and multi-CAR cell combination therapy, offer synergistic potential by modulating the TME and improving CAR-cell functionality. …”
    Get full text
    Article
  16. 1116

    Role of Tumor Necrosis Factor in Tuberculosis by Fedor D. Kireev, Julia A. Lopatnikova, Alina A. Alshevskaya, Sergey V. Sennikov

    Published 2025-05-01
    “…Understanding the pleiotropic functions of TNF in tuberculosis pathogenesis is crucial for developing safe immunomodulatory strategies and optimizing the clinical management of patients at risk of latent TB reactivation.…”
    Get full text
    Article
  17. 1117

    Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model by Shannon Stone, Amany Elsharkawy, J. D. Burleson, Mary Hauser, Arban Domi, Pratima Kumari, Zainab Nabi, Janhavi P. Natekar, Maciel Porto, Brian Backstedt, Mark Newman, Sreenivasa Rao Oruganti, Mukesh Kumar

    Published 2025-04-01
    “…GEO-CM02 vaccine efficacy studies also demonstrated a complete level of vaccine-induced protection with a single dose against the original B.1 virus and B.1.1.529 variant. GEO-CM02 effectively elicited functional T-cell responses in both prime and prime–boost groups. …”
    Get full text
    Article
  18. 1118
  19. 1119

    Pathogenetic Relationship of Immunological Disorders in Chronic Generalized Periodontitis and Rheumatoid Arthritis by G. V. Poryadin, A. N. Zakhvatov, A. Y. Parshina

    Published 2022-05-01
    “…The pathogenetic mechanisms of progression of chronic periodontitis accompanied with rheumatoid arthritis is confirmed by the common parts of immune-inflammatory reactions.Damage to periodontal tissues is indirectly made by cytotoxic effects of enzymes and their metabolites produced by Porphyromonas gingivalis bacteria. …”
    Get full text
    Article
  20. 1120